Moderna Stock Was Up By Over 20% Today | Via News
Moderna stock
Moderna set to file for us, EU clearance for its coronavirus vaccine. According to today's article on ForexLive, “Moderna reaffirms that its vaccine is 94.1% ...
Continue reading on Via News AgencyTrending now
More articles about Moderna stock
Why Moderna Stock Surged Today
The drugmaker is requesting emergency authorization for its coronavirus vaccine candidate.
Continue readingWhat's Happening With Moderna Stock?
Moderna stock rallied by over 10% on Wednesday's trading after the European Union agreed to buy 80 million doses of its Covid-19 vaccine, with an option to ...
Continue readingCoronavirus update: Moderna files for EUA; Novavax prepares for ...
Positive vaccine news boosts sentiment as the country continues to report record hospitalizations.
Continue readingModerna's Stock Hits New Highs After COVID-19 Vaccine Analysis ...
Moderna Inc (NASDAQ: MRNA) shares, which closed in record territory Friday, are adding to their gains following the release of primary analysis of the Phase 3 ...
Continue readingCovid-19: Moderna submits vaccine for FDA regulatory approval
A leading coronavirus vaccine candidate developed by Massachusetts biotech firm Moderna will be submitted for regulatory approval.
Continue readingModerna says new data shows Covid vaccine is more than 94 ...
Moderna will be the second drugmaker to seek emergency use from the FDA after Pfizer applied for the same authorization on Nov. 20.
Continue readingModerna soars 16% after announcing plans to file for emergency ...
Moderna Moderna jumped 16% on Monday after the company said it would file for emergency use authorization for its coronavirus vaccine from the...
Continue readingModerna's stock soars after plan to file for emergency approval of ...
Moderna is moving closer to having its COVID-19 vaccine candidate available for distribution, as the biotechnology company said Monday it plans to request an.
Continue readingModerna Hits A Record High As It Seeks FDA OK For Coronavirus ...
Final-phase testing confirmed that the Moderna coronavirus vaccine is 94.1% effective at blocking Covid-19. Moderna stock surged on Monday.
Continue readingModerna, Inc. (MRNA) - Moderna's Stock Hits New Highs After ...
Moderna Inc (NASDAQ: MRNA) shares, which closed in record territory Friday, are adding to their gains following the release of primary analysis of the ...
Continue readingModerna Stock Is Outta Sight
I think I'll just forget to put a new price target on this name for a while. All of my prior sales were mistakes....MRNA.
Continue readingStocks jump after Moderna releases promising vaccine trial results
S&P 500, Dow hit record high as investors cheer drugmaker's announcement that COVID-19 treatment is 94.5% effective.
Continue readingModerna, Zoom Reveal the Nasdaq's Split Personality
Investors have had a lot to wrestle with lately, but on Monday morning, they got some good news. Although other major market benchmarks got most of the ...
Continue readingModerna's Covid-19 Vaccine Works. What It Means for Moderna ...
The biotech says the first glimpse of its clinical trial results showed its shots cut the rate of infections by 94.5%. Pfizer described its vaccine as more than 90% ...
Continue readingStocks making the biggest moves midday: Moderna, Simon Property ...
Moderna gets a boost from positive vaccine trial data. Tilray shares slide on an analyst downgrade.
Continue readingModerna, Virgin Galactic, PNC: What to Watch When the Stock ...
Here's what we are watching as markets kick into gear Monday. —A 94.5% vaccine result from Moderna boosted stock futures with the S&P 500 set to open ...
Continue readingModerna, PNC, JD.com, Walmart: 5 Things You Must Know Monday
Stock futures soar after Moderna says coronavirus vaccine candidate was 94.5% effective; PNC will acquire the U.S. banking arm of Spain's BBVA for $11.6 ...
Continue readingU.S. stocks jump after Moderna vaccine breakthrough — Here's ...
U.S. stocks jumped, nearing a record 30000 on the Dow, after Moderna said preliminary trial data showed its coronavirus vaccine is more than 94% effective.
Continue readingDow Closes Just Below 30000 Mark
Vaccine news helped Moderna, but Pfizer and BioNTech slipped.
Continue readingDow and S&P 500 hit new record highs after Moderna says vaccine ...
US stocks rallied on Monday after Moderna said its experimental Covid-19 vaccine is highly effective.
Continue readingStocks Close at Records After Positive Moderna Vaccine Results
The Dow industrials and S&P 500 rose following positive study results from another potential Covid-19 vaccine, putting the blue-chip index within striking ...
Continue readingStocks Hit Record High On Moderna's Vaccine News; Dow Nears ...
Investors were also reassured by comments from two Biden advisers that no nationwide COVID-19 lockdowns are being contemplated.
Continue readingDow soars nearly 400 points after clinching intraday record on ...
Stocks rise sharply Monday in a rally fueled by optimism over progress toward a COVID-19 vaccine.
Continue readingStocks Surge After Moderna's Vaccine News Reinforces Hopes ...
Investors were also reassured by comments from two Biden advisers that no nationwide COVID-19 lockdowns are being contemplated.
Continue readingStocks Surge After Moderna's Vaccine News Reinforce Hopes About ...
Investors were also reassured by comments from two Biden advisers that no nationwide COVID-19 lockdowns are being contemplated.
Continue readingDow Hits New High After Positive Moderna Vaccine Results
The Dow industrials and S&P 500 rose following positive study results from another potential Covid-19 vaccine, with the blue-chip index hitting an intraday ...
Continue readingZoom, Peloton, and other 'stay-at-home' stocks tumble after ...
Peloton 'Stay-at-home' stocks including Zoom, Etsy, and Peloton tumbled in pre-market trading on Monday after Moderna revealed its COVID-19 va...
Continue readingCruise stocks surge after Moderna reports upbeat news its COVID ...
Shares of cruise operators charged higher Monday, after Moderna Inc.'s undefined said its COVID-19 vaccine candidate demonstrated better-than 94% efficacy ...
Continue readingZoom, Peloton, Netflix stocks among stay-home names declining ...
Shares of stocks that benefitted from stay-at-home trends are falling again Monday after Moderna Inc. put out a news release saying that its COVID-19 vaccine...
Continue readingWhy Moderna Stock Is Spiking Today
The biotech's COVID-19 vaccine hits the mark in a late-stage trial.
Continue readingDow nears 30K level as COVID-19 vaccine news fuels investor ...
Moderna's CEO Stephane Bancel told FOX Business the vaccine could see FDA approval in the next several weeks to months. “The emergency use approval I ...
Continue readingDow and US stocks rise as Moderna says vaccine is 94.5% effective ...
US stocks rose sharply Monday, on pace to hit new record highs, after Moderna said its experimental Covid-19 vaccine is highly effective. That heralded another ...
Continue readingMonday Morning Stock Market Movers: Moderna, BioNTech, and a ...
Vaccine news sent Moderna and the Dow higher, as Pfizer and BioNTech slipped.
Continue readingModerna Stock Rockets After Coronavirus Vaccine Proves 94.5 ...
Moderna's coronavirus vaccine proved 94.5% effective at an interim analysis of its final test, the biotech company said early Monday. Moderna stock popped.
Continue readingStock market live updates: Futures rise, Moderna jumps after Trump ...
This is CNBC's live blog that will be updated throughout the day.
Continue readingKamala Harris, Tesla, Moderna, Cisco - 5 Things You Must Know ...
Uncertainty remains over the next virus aid package; California Sen. Kamala Harris is chosen as Joe Biden's running mate; Tesla splits its stock five-for-one.
Continue readingModerna Spikes 11% On $1.5B US Supply Deal For Covid-19 Vaccine
Shares in Moderna (MRNA) spiked 11% in Tuesday's after-hours trading after the company announced a $1.525 billion supply deal with the U.S. government for ...
Continue readingTrump administration buys 100 million doses of Moderna's vaccine
The U.S. government has agreed to buy 100 million doses of Moderna's experimental coronavirus vaccine for $1.5 billion, or $15 per dose. Why it matters: The ...
Continue readingUS government to buy 100 million doses of COVID-19 trial vaccine ...
The US announced a deal Tuesday with pharmaceutical company Moderna to manufacture 100 million doses of its experimental coronavirus vaccine.
Continue readingModerna's Coronavirus Treatment Transforms Body Into Vaccine ...
The U.S. company and its German rival BioNTech plan to use RNA as a messenger inside cells to produce an immune reaction. The advance could upend ...
Continue readingModerna reveals it may not hold patent rights for coronavirus vaccine
Moderna said in new financial filings that it "cannot be certain that we were the first to make the inventions claimed in our patents or pending patent applications" ...
Continue readingUS government strikes deal with Moderna for 100M coronavirus ...
In a press release on Tuesday, Moderna said the deal is valued at up to $1.5 billion, and gives the government the option to buy another 400 million doses.
Continue readingModerna Strikes $1.5B Supply Agreement With US For 100M Doses ...
Moderna Inc (NASDAQ: MRNA) is getting a boost Tuesday afternoon after announcing a coronavirus vaccine agreement with the U.S. government.
Continue readingModerna stock pops after agreement to sell at least 100 million ...
Moderna Inc. undefined announced Tuesday afternoon that it has reached an agreement to sell 100 million doses of its investigational vaccine for COVID-19 to...
Continue readingWhat Will Moderna Look Like Post Covid-19?
Moderna's stock has rallied almost 4x since the beginning of this year, rising from levels of about $20 to near $75 currently. However, we believe the vaccine, ...
Continue readingTrump says U.S. has reached deal with Moderna for 100 million ...
President Donald Trump on Tuesday announced the U.S. government will purchase 100 million doses of Moderna's experimental coronavirus vaccine. Moderna ...
Continue readingModerna share price: positive Oxford vaccine and JPMorgan ...
Moderna's share price slumps after JPMorgan downgrades the stock to neutral. A positive early trial for rival AstraZeneca's Covid-19 vaccine response is adding ...
Continue reading3 "High-Flying" Coronavirus Vaccine Stocks
AstraZeneca PLC ADR(NYSE:AZN): One of the most exciting stories is the race to develop a coronavirus vaccine. Currently, Moderna (MRNA), AstraZeneca ...
Continue readingWhy Moderna Stock Plunged Today
Shares of Moderna (NASDAQ:MRNA) fell sharply on Monday, following an analyst downgrade and positive vaccine trial results from a rival drugmaker. By the ...
Continue readingModerna Hype Is About to End in Tears: JPMorgan
Moderna has been on a tear since the start of the year. It's about to end in tears as the stock is trading at insanely high levels.
Continue readingStocks making the biggest moves midday: Amazon, BioNTech ...
Pfizer and BioNTech rise on positive coronavirus vaccine data. Amazon surges on a big price-target hike.
Continue readingModerna Stock Options Hot After Rare Downgrade
The shares of Moderna Inc (NASDAQ:MRNA) are floundering today, last seen off 11% at $84.36, after receiving a downgrade from J.P. Morgan Securities to ...
Continue readingHere's why JPMorgan just downgraded Moderna stock, despite ...
JPMorgan has downgraded shares in COVID-19 vaccine maker Moderna's stock over valuation concerns. The drop is from overweight to neutral.
Continue readingMarkets Open Mixed Monday Morning; AstraZeneca Reveals COVID ...
Market participants still aren't sure what to expect as earnings season continues.
Continue readingModerna Falls on Downgrade, Oxford-AstraZeneca Vaccine Data
Moderna falls after J.P. Morgan downgrades the stock and an Oxford-AstraZeneca study suggests promising results from their own coronavirus vaccine trials.
Continue readingJPMorgan downgrades Moderna on valuation concerns after 380 ...
Shares of Moderna have skyrocketed a whopping 384% this year as investors bet that it will become one of the first drugmakers to develop a viable coronavirus ...
Continue readingModerna Stock Might Not Be The Play For Moderna Bulls
Optimism toward Moderna's coronavirus vaccine drove MRNA stock higher last week — but appears to have boosted other names as well, at least momentarily.
Continue readingModerna (MRNA) Stock Down 9.68% as Other Vaccine Developers ...
Moderna Inc (MRNA) is down -9.68% today as competing COVID-19 vaccine researchers Pfizer, BioNTech, AstraZeneca, and Oxford University all released ...
Continue readingModerna Gets a Downgrade from J.P. Morgan
Moderna, one of the front-runners in the race to develop a coronavirus vaccine, gets a downgrade from J.P. Morgan - but only over valuation concerns.
Continue readingThe Race To Save The Race
Dr Anurag Yadav - Covid vaccines are on fast-track, accelerated development around the world. Who ever wins, humanity will be the ultimate beneficiary., ...
Continue readingModerna Stock's Valuation Is Just Too High, Analyst Says. It's Now ...
J.P. Morgan analyst Cory Kasimov downgraded the stock to Neutral, from Overweight, and set a target of $89 for the stock price.
Continue readingJ.P. Morgan downgrades Moderna over valuation concerns
Analysts at J.P. Morgan downgraded shares of Moderna Inc. undefined to neutral from overweight over concerns about the valuation of the preclinical company,.
Continue readingModerna Plunges On Downgrade — Is Coronavirus Vaccine Maker ...
Moderna stock fell Monday on a downgrade after an analyst suggested the coronavirus vaccine maker is overvalued. He now has a neutral rating on MRNA ...
Continue readingHere are Monday's biggest analyst calls of the day: Starbucks ...
(This story is for CNBC PRO subscribers only.) Here are the biggest calls on Wall Street on Monday: Jefferies raised its price target on Amazon to a Street high of ...
Continue readingStocks making the biggest moves midday: Home Depot, Moderna ...
Check out the companies making headlines in midday trading. Mastercard — Shares of Mastercard fell 6.7% after the credit card company issued a warning that ...
Continue readingIntuit, Moderna Rise; Mastercard, Shake Shack Fall
Stocks that moved heavily or traded substantially on Tuesday:
Continue readingModerna Stock Surges After Coronavirus Vaccine Development
Drug stock Moderna (MRNA) is breaking out once more after a positive development for its coronavirus vaccine.
Continue readingModerna touts possible coronavirus vaccine mRNA-1273 - CNN
US biotech firm Moderna has shipped an experimental coronavirus vaccine to US government researchers just six weeks after it started working on the ...
Continue readingModerna Surges After Shipping Coronavirus Vaccine for Human Trials
Moderna shares spiked higher Tuesday after the Cambridge, Mass.-based biotech said it had put forward a new coronavirus vaccine for a phase one study.
Continue readingWhy Moderna Stock Is Rocketing Higher Today
Mid-cap biotech Moderna (NASDAQ:MRNA) is on the move again today. Shares are up by a noteworthy 11.7% as of 10:23 a.m. EST Tuesday. Moderna's shares ...
Continue readingBad News About the Coronavirus Is Good News for Moderna's ...
The biotech firm Moderna announced Monday night that it had shipped vials of its experimental coronavirus vaccine to the National Institutes of Health for ...
Continue readingModerna's stock rises as it ships the first batch of its COVID-19 ...
Shares of Moderna Inc. soared 28% in trading on Tuesday as the biotechnology company took the lead in efforts to develop a vaccine for COVID-19, the novel...
Continue readingHot biotech Moderna spikes 22% as it ships the first potential ...
Biotech company Moderna jumped as much as 22% on Tuesday after the firm shipped the first coronavirus vaccine for phase one testing in the US. M...
Continue reading